I see what you're saying. I think the biggest "problem" is the sweeping generalizations that come about regarding Big Pharma Greed and all that. I can't speak to what the corporate strategy is for each company on rare vs. common vs. "new" diseases, but there are numerous entities at fault in terms of the…